Cyclobenzaprine Hydrochloride
Product Images NDC 10544-200

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 10544-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (6afbcc98 Figure 01)

Chemical structure and molecular formula of Cyclobenzaprine Hydrochloride, showing the three-ring skeleton and its associated hydrochloride salt.*

FDA Label Image

Logo (6afbcc98 Figure 02)

FDA Label Image

5mg 30ct (Label Cyclobenzaprine HCl Tabs 5mg Bpi(10544 200 30) Kvk(10702 006 01) Rev2)

Cyclobenzaprine Hydrochloride Tablets, USP 5mg, packaged in a bottle containing 30 tablets. The label shows the product name, strength, dosage form, quantity, and manufacturer, Blenheim Pharmacal, Inc. It includes storage instructions and notes the product is prescription only with directions to see the package insert for dosage information. The label also displays NDC 10544-200-30 and manufacturing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.